Sultan M, Nawaz F, Alattar B, Khalaf E, Shadan S, El-Abiary N
BMC Pediatr. 2025; 25(1):32.
PMID: 39810118
PMC: 11730125.
DOI: 10.1186/s12887-024-05310-z.
Pan Y, Cheng X
Front Psychiatry. 2020; 11:301.
PMID: 32390881
PMC: 7193689.
DOI: 10.3389/fpsyt.2020.00301.
Mazursky-Horowitz H, Thomas S, Woods K, Chrabaszcz J, Deater-Deckard K, Chronis-Tuscano A
J Abnorm Child Psychol. 2017; 46(3):463-475.
PMID: 28361338
PMC: 5623161.
DOI: 10.1007/s10802-017-0289-2.
Hamed A, Kauer A, Stevens H
Front Psychiatry. 2015; 6:168.
PMID: 26635643
PMC: 4659921.
DOI: 10.3389/fpsyt.2015.00168.
Sterley T, Howells F, Dimatelis J, Russell V
Metab Brain Dis. 2015; 31(1):169-82.
PMID: 26464063
DOI: 10.1007/s11011-015-9742-5.
Speech-Sound Disorders and Attention-Deficit/Hyperactivity Disorder Symptoms.
Lewis B, Short E, Iyengar S, Taylor H, Freebairn L, Tag J
Top Lang Disord. 2013; 32(3):247-263.
PMID: 24363479
PMC: 3868495.
DOI: 10.1097/tld.0b013e318261f086.
Response inhibition and ADHD traits: correlates and heritability in a community sample.
Crosbie J, Arnold P, Paterson A, Swanson J, Dupuis A, Li X
J Abnorm Child Psychol. 2013; 41(3):497-507.
PMID: 23315233
PMC: 3600128.
DOI: 10.1007/s10802-012-9693-9.
Influence of a latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD).
Fallgatter A, Ehlis A, Dresler T, Reif A, Jacob C, Arcos-Burgos M
Eur Neuropsychopharmacol. 2012; 23(6):458-68.
PMID: 23245769
PMC: 4131948.
DOI: 10.1016/j.euroneuro.2012.11.001.
Effects of early life trauma are dependent on genetic predisposition: a rat study.
Sterley T, Howells F, Russell V
Behav Brain Funct. 2011; 7:11.
PMID: 21548935
PMC: 3104368.
DOI: 10.1186/1744-9081-7-11.
Dopamine transporter (SLC6A3) genotype impacts neurophysiological correlates of cognitive response control in an adult sample of patients with ADHD.
Dresler T, Ehlis A, Heinzel S, Renner T, Reif A, Baehne C
Neuropsychopharmacology. 2010; 35(11):2193-202.
PMID: 20631685
PMC: 3055310.
DOI: 10.1038/npp.2010.91.
Advances in genetic studies of attention-deficit/hyperactivity disorder.
Smith A, Mick E, Faraone S
Curr Psychiatry Rep. 2009; 11(2):143-8.
PMID: 19302768
DOI: 10.1007/s11920-009-0022-0.
Neuropsychological endophenotype approach to genome-wide linkage analysis identifies susceptibility loci for ADHD on 2q21.1 and 13q12.11.
Rommelse N, Arias-Vasquez A, Altink M, Buschgens C, Fliers E, Asherson P
Am J Hum Genet. 2008; 83(1):99-105.
PMID: 18599010
PMC: 2443830.
DOI: 10.1016/j.ajhg.2008.06.006.
Speed, variability, and timing of motor output in ADHD: which measures are useful for endophenotypic research?.
Rommelse N, Altink M, Oosterlaan J, Beem L, Buschgens C, Buitelaar J
Behav Genet. 2007; 38(2):121-32.
PMID: 18071893
PMC: 2257997.
DOI: 10.1007/s10519-007-9186-8.
Reaction time performance in ADHD: improvement under fast-incentive condition and familial effects.
Andreou P, Neale B, Chen W, Christiansen H, Gabriels I, Heise A
Psychol Med. 2007; 37(12):1703-15.
PMID: 17537284
PMC: 3770126.
DOI: 10.1017/S0033291707000815.
Environmental influences that affect attention deficit/hyperactivity disorder: study of a genetic isolate.
Pineda D, Palacio L, Puerta I, Merchan V, Arango C, Galvis A
Eur Child Adolesc Psychiatry. 2007; 16(5):337-46.
PMID: 17487441
DOI: 10.1007/s00787-007-0605-4.
Gestational age, birth weight, and the risk of hyperkinetic disorder.
Linnet K, Wisborg K, Agerbo E, Secher N, Thomsen P, Henriksen T
Arch Dis Child. 2006; 91(8):655-60.
PMID: 16754656
PMC: 2083047.
DOI: 10.1136/adc.2005.088872.
Lack of a relation between human neonatal thyroxine and pediatric neurobehavioral disorders.
Soldin O, Lai S, Lamm S, Mosee S
Thyroid. 2003; 13(2):193-8.
PMID: 12699594
PMC: 3641764.
DOI: 10.1089/105072503321319503.
Newborn thyroxine levels and childhood ADHD.
Soldin O, Nandedkar A, Japal K, Stein M, Mosee S, Magrab P
Clin Biochem. 2002; 35(2):131-6.
PMID: 11983348
PMC: 3635835.
DOI: 10.1016/s0009-9120(02)00284-9.